CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

August 12, 2022 · earnings

CMMB earnings: a positive outcome, +7.2%

On August 12, 2022, Chemomab Therapeutics Ltd. reached its earnings. The result was a positive outcome, and the stock moved +7.2% in the window around the event. It had already run +10.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$14.92
1d before
$16.00
Event day
$16.00
1d after
$13.08
5d after

Pre-catalyst setup

+10.1%
30-day run-up
6329%
30-day volatility
2.2×
volume spike